The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
about
Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet studyManagement of venous thromboembolism during pregnancy.Evidence-based approach to thrombophilia testing.A Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR) for the Detection of Factor V Leiden and Prothrombin G20210A.Prothrombotic risk factors and antithrombotic therapy in children with ischemic strokeEpidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.Hormones and pregnancy: thromboembolic risks for women.Medical management of venous thromboembolism: what the interventional radiologist needs to knowThrombosis in systemic lupus erythematosus: a review articleTesting for thrombophilia: an evidence-based approach.Management of inherited von Willebrand disease in 2007.Factor V Leiden and FII 20210 testing in thromboembolic disorders.Inherited risk factors for venous thromboembolism.Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease.Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias.Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer--a prospective study.The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism.Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster.The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study.Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.Thrombophilia Screening: Universal, Selected, or Neither?Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias
P2860
Q24650582-10454B9A-18F6-4918-BA94-D2C1B77828C2Q33349065-67598403-7138-4686-B8D2-98D5DB151C5CQ34663749-CF18EB66-C714-42AA-B02A-BAFBBECE42CEQ35146858-CE3B016F-1EBF-42BC-A9BD-7440EF63FD41Q35168617-D9AF7656-0817-493E-936E-A5D99CA1123BQ35640739-FAE58FAF-25F3-40C0-A252-3C1635F919FAQ35852845-99421C73-D83B-4B75-B2A0-FD16C91A0ECDQ35948292-90AEB347-7E51-4187-9158-60504DA80B2FQ36147794-C17153F8-956C-49F7-9278-D493908206E1Q36651065-E4B07A3F-C9D3-42F3-A66E-D1047087322AQ36911419-BB1056DA-4821-4C0F-A8AB-F4DFB786DA68Q37810984-31AA9D8B-9288-4754-830E-95B4AA63AF7FQ38178063-8E5527EC-95B6-41B0-A0BF-99BD94520E51Q39276259-E15A2AB5-B2D8-498A-BCBA-2CBAF0177EF0Q39971724-17073ADB-570B-40A7-A69E-7DDD051A01BBQ43008443-58782DD9-49EE-4527-BC16-77DF5C713AB6Q43677009-EE96D5E7-8AA1-4A6D-B6DA-70B3F93F8C20Q43976757-0AF93107-21A2-4C5B-9F84-2A26ED41CBE2Q45874308-E46E5147-45B7-4B24-B119-7DE47920F561Q45880590-B38A6BE5-4EE1-463B-A19B-1E6EE4BC2329Q47906849-E6404AE3-1CCA-40EC-9D6C-2D49C99EC6F1Q50763847-AC57475E-26EF-43E2-A722-3BA1B65844A3Q51329060-933129B4-1627-4262-96EA-757CE8C6DD12Q53812184-F68CB120-8A09-4B19-BBD1-8568E1DEDC62Q53963871-4701543A-B2AD-4F8F-A07B-59FDFCB11A50Q57573583-7DEE0FDC-060E-4FC0-B340-7A5C034A4B3D
P2860
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@en
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@nl
type
label
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@en
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@nl
prefLabel
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@en
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@nl
P2860
P50
P1476
The risk of venous thromboembo ...... ctor V or prothrombin or both.
@en
P2093
Castaman G
Mannucci PM
P2860
P304
P356
10.1046/J.1365-2141.2000.02502.X
P407
P577
2000-12-01T00:00:00Z